Publications by authors named "M Robson"

Claim this Profile
K
KEYLYNK-009: Pembrolizumab Plus Olaparib in Locally Recurrent Inoperable or Metastatic Triple-Negative Breast Cancer and Clinical Benefit From First-Line Pembrolizumab Plus Chemotherapy.
Hope S Rugo, David W Cescon, Mark E Robson, Seock-Ah Im, Florence Dalenc

Clin Cancer Res· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capivasertib plus paclitaxel as first-line treatment for metastatic triple-negative breast cancer: Results from the randomised, global phase III CAPItello-290 trial.
P S Schmid, H L McArthur, J Cortés, B Xu, F Cardoso, M E Robson

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Variation in caesarean section rates according to the Robson classification in four low- and middle-income countries: a meta-analysis of groups 1 to 4.
Marion Ravit, Camille Etcheverry, Charles Kabore, Pisake Lumbiganon, Guillermo Carroli, Mike Robson

BMC Pregnancy Childbirth· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Postfeminist Healthism: Understanding the Gendering of Healthism Using Menstrual Tracking Apps as an Example.
Sarah Riley, Adrienne Evans, Martine Robson

Sociol Health Illn· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Impact of Breast Cancer Polygenic Risk Score Disclosure on Decisional Conflict Around Risk-Reducing Mastectomy in Carriers.
Giulia Ongaro, Caroline Salafia, Rania Sheikh, Elizabeth Schofield, Dana Farengo Clark, Mark E Robson

medRxiv· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis